1- American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2015. 38 S8–S16. (10.2337/dc15-S005) [PubMed] [CrossRef]
2- Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nature Reviews Endocrinology 2013. 9 513–521. (10.1038/nrendo.2013.86) [PubMed] [CrossRef]
3- Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001. 358 221–229. (10.1016/S0140-6736(01)05415-0) [PubMed] [CrossRef].
4- Shujuan Liu, Haixia Li. Down-regulation of microRNA-28 in peripheral blood mononuclear cell plays a role in pathogenesis of type 1 diabetes. Int J Clin Exp Med 2017;10 (7):10021-10030
5- Barutta F, Bellini S, Mastrocola R , Bruno G, and Gruden G. MicroRNA and Micro-vascular Complications of Diabetes.(2018); International Journal of Endocrinology, https://doi.org/10.1155/2018/6890501.
6-Simranjeet Kaur, Flemming Pociot.(2018); miRNAs regulate development and function of regulatory T-cells in recent onset islet autoimmunity in pre-Type 1 diabetes. doi: 10.21037/ncri.2018.03.06.
7- Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20.
8- Sebastiani G, Spagnuolo I, Patti A, et al. MicroRNA expression fingerprint in serum of type 1 diabetic patients. Diabetologia. 2012; 55:S48.
9- Nielsen LB, Wang C, Sørensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res. 2012:896362.
10- Lin S & Gregory RI. MicroRNA biogenesis pathways in cancer. Nature Reviews Cancer (2015) 321–333. (doi:10.1038/nrc3932).
11-Abuhatzira L, Xu H, Tahhan G, Boulougoura A et al. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2beta, and GAD65. FASEB Journal (2015) 29 4374–4383. (doi:10.1096/fj.15- 273649).
12-Trinder P: Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. J Ann Clin Biochem(1969); 6: 24-25.
13-Gonen B and Rubenstien AH: Determination of glycohemoglobin. Diabetologia (1978); 15:1-5.
14- Ardekani AM and Naeini M: The role of microRNAs in human diseases. Avicenna J Med Biotechnol 2: 161‑179, 2010.
15- Pandey AK, Agarwal P, Kaur K and Datta M: MicroRNAs in diabetes: Tiny players in big disease. Cell Physiol Biochem 23: 221‑232, 2009.
16- Bhatt K, Mi QS and Dong Z: MicroRNAs in kidneys: Biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 300: F602‑F610, 2011.
17- Butz H, Kinga N, Racz K & Patocs A. Circulating miRNAs as biomarkers for endocrine disorders. Journal of Endocrinological Investigation 2016 39 1–10. (doi:10.1007/s40618-015-0316-5)
18- Carrington JC & Ambros V. Role of microRNAs in plant and animal development. Science 2003 301 336–338. (doi:10.1126/ science.1085242)
19- Lin S & Gregory RI. MicroRNA biogenesis pathways in cancer. Nature Reviews Cancer 2015 15 321–333. (doi:10.1038/nrc3932)
20- Pauley KM, Cha S & Chan EK. MicroRNA in autoimmunity and autoimmune diseases. Journal of Autoimmunity 2009 32 189–194. (doi:10.1016/j.jaut.2009.02.012)
21- Zalts H & Shomron N. The impact of microRNAs on endocrinology. Pediatric Endocrinology Reviews 2011 8 354–362.
22-Akerman L, Casas R, Ludvigsson J, Tavira B, Skoglund C. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in
children with high risk for type 1 diabetes. PLoS ONE 13(1): e0191067. https://doi. org/10.1371/journal.pone.0191067
23- Esteller M. Non-coding RNAs in human disease. Nature Reviews Genetics 2011 12 861–874. (doi:10.1038/nrg3074).
24- Butz H, Kinga N, Racz K & Patocs A. Circulating miRNAs as biomarkers for endocrine disorders. Journal of Endocrinological Investigation 2016 39 1–10. (doi:10.1007/s40618-015-0316-5)
25- M. van de Bunt, K. J. Gaulton , L. Pfarts et al., “The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis,” PLoS ONE, vol. 8, no. 1, article e55272, 2013.
26- Marchand L, Jalabert A, Meugnier E, Vanden K, Fabien N, Nicolino M, Madec A.M., Thivolet C and Kone S: Mi-RNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children With Newly Diagnosed Type1Diabetes. Journal of Diabetes Research. http://doi.org/ 10.1155/2016/1869082.
27- Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Zhou H, Tang Y & Shen N. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyl transferase 1. Open Journal of Immunology 2010 184 6773–6781. (doi:10.4049/jimmunol.0904060)
28- Osipova J, Fischer DC, Dangwal S, Volkmann I, Widera C, Schwarz K, Lorenzen JM, Schreiver C, Jacoby U, Heimhalt M, Thum T, Haffner D. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. J Clin Endocrinol Metab. 2014; 99(9):E1661-5.
29- Backe MB, Novotny GW, Christensen DP, Grunnet LG & Mandrup- Poulsen T. Altering beta-cell number through stable alteration of miR-21 and miR-34a expression. Islets 2014 6 e27754. (doi:10.4161/ isl.27754)
30-Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y & O'Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nature Immunology 2010 11 141–147. (doi:10.1038/ni.1828).
31-Ventriglia G, Nigi L, Sebastiani G & Dotta F. MicroRNAs: novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes. BioMed Research International 2015 2015 749734.
32-Santos A, Cunha N, Fukui R, Ferreira R.P, and Silva M: Increased expression of circulatory micro RNA101-in Type1Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type1Diabetes. Frontiers in Immunology, (2019). Doi: 10.3389/ Fimmu. 2019.01637.
33-Kassem S, Ariel I, Thornton P, Scheimberg I, Glaser B: Beta cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes (2000). 49:1325-33.doi: 10.2337/ diabetes.49.8.1325.
34- Tugay K, Guay C, Marques A, Allagnat F, Locke J, Harries L W, et al.:Role of micro RNA in the age-associated decline of pancreatic beta cell function in rat islets. Diabetologia. (2016) 59:161-9. doi: 10.1007/s00125-015-3783.
35- Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, Yoshimura A, Baltimore D & Rudensky AY. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010 142 914–929. (doi:10.1016/j.cell.2010.08.012)
36- Tian C, Ouyang X, Lv Q, Zhang Y & Xie W. Cross-talks between microRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic mice. Biomedical Reports 2015 3 333–342.
37- Erener S, Marwaha A, Tan R, Panagiotopoulos C, Kieffer TJ. Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. JCI Insight. 2017; 2(4):e89656.
38- Wang H, Peng W, Shen X, Huang Y, Ouyang X and Dai Y: Circulating levels of inflammation‑associated miR‑155 and endothelial‑enriched miR‑126 in patients with end‑stage renal disease. Braz J Med Biol Res 45: 1308‑1314, 2012.
39- Harris TA, Yamakuchi M, Ferlito M, Mendell JT and Lowenstein CJ: MicroRNA‑126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105: 1516‑1521, 2008.
40- Jiang Y, Wang HY, Li Y, Guo SH, Zhang L and Cai JH: Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep 4: 5026, 2014.
41-Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215‑233, 2009.
42- Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, et al: Plasma microRNA profiling reveals loss of endothelial miR‑126 and other microRNAs in type 2 diabetes. Circ Res 107: 810‑817, 2010.
43- Bijkerk R, Duijs JM, Khairoun M, Ter Horst CJ, van der Pol P, Mallat MJ, Rotmans JI, de Vries AP, de Koning EJ, de Fijter JW, et al: Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas‑kidney transplantation. Am J Transplant 15: 1081‑1090, 2015.